All Stories

  1. Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy

    Article • Cancer Management and Research, November 2018, Dove Medical Press

    Prof Michael Thomas

  2. nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy

    Article • Lung Cancer Targets and Therapy, October 2017, Dove Medical Press

    Prof Michael Thomas, Dr Oscar Juan, Amy Ko

  3. Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma

    Article • Genes Chromosomes and Cancer, November 2016, Wiley

    Prof Michael Thomas

  4. Patients with advanced lung cancer and their relatives

    Article • Patient Preference and Adherence, October 2016, Dove Medical Press

    Dr Dominik Ose, Dr. Sinikka Gusset-Baehrer, Prof Michael Thomas

  5. Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer

    Article • European Respiratory Journal, March 2015, European Respiratory Society (ERS)

    Prof Michael Thomas